Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy
NCT ID: NCT04917510
Last Updated: 2021-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2021-07-31
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Lumbar Erector Spinae Plane Block and Pericapsular Nerve Group Block in Patients Undergoing Hip Surgeries
NCT05930171
Hip Scope Fascia-iliaca (FI) Block Study
NCT02365961
Erector Spinae vs. PENG Block for Total Hip Arthroplasty
NCT06083428
Erector Spinae vs Fascia Iliaca Block in Hip Arthroplasty
NCT03860324
Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy
NCT04925791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Will not receive erector spinae block. Will be administered 30 mL of 0.5% Marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.
Local block
See control and study arm group descriptions for the local block
Study
Will receive an erector spinae block prior to surgery using 30-45 mL of 0.25 bupivacaine w/ epinephrine and 5 mL of dexmedetomidine. Will be administered 30 mL of 0.5% marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.
Erector spinae block
See experimental arm group description
Local block
See control and study arm group descriptions for the local block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector spinae block
See experimental arm group description
Local block
See control and study arm group descriptions for the local block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 13-50
* Individuals who have the capacity to provide consent or assent for themselves
Exclusion Criteria
* Revision surgery
* Known narcotic use in the 6 months prior to surgery
* Workman's compensation patient
* Pregnancy
13 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carilion Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Coobs, MD
Role: PRINCIPAL_INVESTIGATOR
Carilion Clinic Ortho Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Orthopedics and Neurosciences
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-21-1223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.